Cargando…
APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer’s Disease
Biomarker definitions for preclinical Alzheimer’s disease (AD) have identified individuals with neurodegeneration (ND+) without β-amyloidosis (Aβ-) and labeled them with suspected non-AD pathophysiology (SNAP). We evaluated Apolipoprotein E (APOE) ε2 and ε4 allele frequencies across biomarker defini...
Autores principales: | Hohman, Timothy J., Dumitrescu, Logan, Oksol, Amy, Wagener, Madison, Gifford, Katherine A., Jefferson, Angela L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708777/ https://www.ncbi.nlm.nih.gov/pubmed/29190651 http://dx.doi.org/10.1371/journal.pone.0188501 |
Ejemplares similares
-
Amyloid imaging in prodromal Alzheimer's disease
por: Ossenkoppele, Rik, et al.
Publicado: (2011) -
Polygenic resilience score may be sensitive to preclinical Alzheimer’s disease changes
por: Eissman, Jaclyn M., et al.
Publicado: (2023) -
Telomere length associations with cognition depend on Alzheimer's disease biomarkers
por: Mahoney, Emily R., et al.
Publicado: (2019) -
Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
por: Saint-Aubert, Laure, et al.
Publicado: (2013) -
Evaluation of choroidal thickness in prodromal Alzheimer’s disease defined by amyloid PET
por: López-de-Eguileta, Alicia, et al.
Publicado: (2020)